{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:29:36Z","timestamp":1769102976007,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The United Kingdom is committed to eliminating hepatitis C virus (HCV) infection by 2025. The prison estate provides an opportunity to identify and treat HCV\u2010positive individuals in a high\u2010prevalence environment. We designed and implemented a pathway of care within a London prison to diagnose, stratify and link HCV\u2010positive prisoners into care. This study was a two\u2010phase case study of a HCV care pathway. New arrivals to the prison were offered blood\u2010borne virus screening with dried blood spot testing at their secondary health check. Those with active infection completed disease stratification tests and were reviewed at a weekly hospital\u2010based multidisciplinary team meeting to determine management. In Phase\u20102, the pathway was redesigned to improve testing and the referral of HCV\u2010positive prisoners into treatment. Over the 30\u2010month evaluation period, 12,946 people were received in the prison. During Phase\u20101, 19.6% of new arrivals completed blood\u2010borne virus testing, with 7.3% identified as HCV\u2010positive. Just 8.3% of HCV\u2010positive individuals were treated or referred for treatment in Phase\u20101. During Phase\u20102, 30% of new receptions completed BBV testing and 3.9% were identified as HCV\u2010positive. Linkage into care was improved, with 38.9% treated or referred during the second phase. Poor access to testing and referral to treatment limit the effectiveness of care provision for prisoners with HCV. Elimination of HCV in prisons requires local service configuration to ensure high uptake of testing, with all HCV\u2010positive cases then offered treatment during custody or referral on to treatment after release.<\/jats:p>","DOI":"10.1111\/jvh.13336","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T20:20:15Z","timestamp":1590438015000},"page":"987-995","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Detection, stratification and treatment of hepatitis C\u2013positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-1756","authenticated-orcid":false,"given":"Declan","family":"Connoley","sequence":"first","affiliation":[{"name":"Monash University Clayton Vic. Australia"},{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"},{"name":"Monash Health Australia Clayton Vic. Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Francis\u2010Graham","sequence":"additional","affiliation":[{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Storer","sequence":"additional","affiliation":[{"name":"Health in Justice NHS England London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nnenna","family":"Ekeke","sequence":"additional","affiliation":[{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-2304","authenticated-orcid":false,"given":"William","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Division of Medicine Institute for Liver and Digestive Health University College London London UK"},{"name":"Royal Free London NHS Foundation Trust London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"NHS England's plan to eliminate Hepatitis C decisively backed by High Court","year":"2019"},{"key":"e_1_2_9_3_1","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20132021","author":"WHO","year":"2016"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103345"},{"key":"e_1_2_9_5_1","volume-title":"Prevalence of blood\u2010borne viruses and injecting risk behaviours among people who inject drugs (PWID) attending injecting equipment provision (IEP) services in Scotland, 2008\u201309 to 2017\u201318","author":"McAuley AP","year":"2019"},{"key":"e_1_2_9_6_1","volume-title":"Managing the prison estate","author":"House of Commons Comittee Public Accounts","year":"2014"},{"key":"e_1_2_9_7_1","unstructured":"Health Protection Agency and Department of Health.Health protection in prisons 2009\u20102010 report.London UK;2011."},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26387"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckr083"},{"key":"e_1_2_9_10_1","unstructured":"World Health Organisation.Global Hepatitis report.Geneva Switzerland.https:\/\/www.who.int\/hepatitis\/publications\/global\u2010hepatitis\u2010report2017\/en\/. April 2017. Accessed March 25 2020."},{"key":"e_1_2_9_11_1","unstructured":"Health Protection Scotland and Glasgow Caledonian University.Blood borne viruses and sexually transmitted infections. Scotland. December 2017."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1133"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1108\/IJPH-09-2014-0032"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280208094691"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.3.153"},{"key":"e_1_2_9_17_1","unstructured":"Public Health England.Blood\u2010borne virus opt\u2010out testing in prisons: preliminary evaluation of pathfinder programme phase 1 April\u2010September 2014.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/769002\/BBV_pathfinder_evaluation_Phase_1_FINAL.PDF. Health Protection Report;2015."},{"key":"e_1_2_9_18_1","unstructured":"Public Health England.Summary report: National engagement event for blood\u2010 borne virus (BBV) opt\u2010out testing in prisons in England 2017.London UK;2017. November 30 2017."},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27567"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0840470416658905"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-2016-003200"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000179"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.019"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-3970-z"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0617"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0602"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9421-0"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13783"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13017"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13071"},{"key":"e_1_2_9_33_1","unstructured":"Public Health England.Annual report from the sentinel surveillance study of blood borne virus testing in England: data for January to December 2015.https:\/\/www.gov.uk\/government\/publications\/sentinel\u2010surveillance\u2010of\u2010blood\u2010borne\u2010virus\u2010testing\u2010in\u2010england\u20102015. Health Protection Report.2016;10. Accessed March 25 2020."},{"key":"e_1_2_9_34_1","unstructured":"Public Health England.Annual report from the sentinel surveillance study of blood borne virus testing in England: data for January to December 2016. Health Protection Report.2017;11.https:\/\/www.gov.uk\/government\/publications\/sentinel\u2010surveillance\u2010of\u2010blood\u2010borne\u2010virus\u2010testing\u2010in\u2010england\u20102016. Accessed March 25 2020."},{"key":"e_1_2_9_35_1","unstructured":"Public Health England.Annual report from the sentinel surveillance study of blood borne virus testing in England: data for January to December 2017.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/746268\/hpr3618_bbv\u2010ss_spplmntry\u2010tbls.pdf. Health Protection Report.2018;12. Accessed March 25 2020."},{"key":"e_1_2_9_36_1","unstructured":"Public Health England.Annual report from the sentinel surveillance study of blood borne virus testing in England: data for January to December 2013.https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/345716\/hpr2914_senthep.pdf. Health Protection Report.2014;8. Accessed March 25 2020."},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26552"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0604-3"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14271"},{"issue":"2","key":"e_1_2_9_40_1","first-page":"64","article-title":"Managing hepatitis C in general practice","volume":"40","author":"Strasser SI","year":"2017","journal-title":"Australian prescriber"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X675421"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdu022"},{"key":"e_1_2_9_43_1","unstructured":"University of the West of Scotland Health Protection Scotland University of Strathclyde West of Scotland Specialist Virology Centre.The Needle Exchange Surveillance Initiative (NESI): prevalence of HCV and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland 2008\/2009 & 2010.Glasgow UK:University of the West of Scotland; September2012."}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.13336","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13336","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.13336","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T02:56:13Z","timestamp":1693882573000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1111\/jvh.13336"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13336","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"2019-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}